ESC Professional Premium Access

Inflammation: a new target in cardiovascular disease prevention

Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Symposium
Date: 29 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Autoimmune diseases and cardiovascular risk.

Speaker: Professor N. Sattar (Glasgow, GB)
Thumbnail

Targeting Interleukin-1 in cardiovascular disease prevention.

Speaker: Professor W. Koenig (Munich, DE)
Thumbnail

Targeting Interleukin-6 signalling in cardiovascular disease prevention.

Speaker: Associate Professor B. Gigante (Stockholm, SE)
Thumbnail

Inflammation: a new target in cardiovascular disease prevention – discussion.

Thumbnail

3 speakers from this session

Professor Naveed Sattar

BHF Glasgow Cardiovascular Research Centre, Glasgow (United Kingdom of Great Britain & Northern Ireland)
33 presentations
2 followers

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)
23 presentations
0 follower

Associate Professor Bruna Gigante

Karolinska Institutet, Stockholm (Sweden)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk